Schor Chen's Form 4 filing
Adicet Bio, Inc. (ACET) · filed Oct 2, 2023
- Accession no.
- 0001209191-23-051259
- Filed
- Oct 2, 2023
- Trade date
- Sep 28-Oct 2, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $15.1K. Open-market sales total $15.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schor ChenCIK 0001340875 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2023 | Common Stock | SSaleDisposed | −5,500 | $1.42 | −$7,810 | 37,969 | Indirect | |
| Sep 28, 2023 | Common Stock | PPurchaseAcquired | +5,500 | $1.42 | +$7,810 | 182,469 | Direct | |
| Sep 29, 2023 | Common Stock | SSaleDisposed | −5,500 | $1.36 | −$7,480 | 176,969 | Direct | |
| Oct 2, 2023 | Common Stock | PPurchaseAcquired | +5,500 | $1.33 | +$7,315 | 43,469 | Indirect | |
| Oct 2, 2023 | Common Stock | FTax withholdingDisposed | −23,208 | $1.37 | −$31,794.96 | 153,761 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.